The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.
The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.
Patent No.:
Date of Patent:
Jul. 25, 2017
Filed:
Jun. 03, 2015
Applicant:
Cerenis Therapeutics Holding SA, Labege, FR;
Inventors:
Daniela Carmen Oniciu, Toulouse, FR;
Jean-Louis Henri Dasseux, Toulouse, FR;
Ronald Barbaras, Seilh, FR;
Oleg Gennadievich Rodin, Moscow, RU;
Anna Rzepiela, Rijswijsk, NL;
Assignee:
Cerenis Therapeutics Holding SA, Labege, FR;
Attorney:
Primary Examiner:
Int. Cl.
CPC ...
A61K 31/5377 (2006.01); A61K 31/4365 (2006.01); A61K 31/155 (2006.01); A61K 31/194 (2006.01); A61K 31/198 (2006.01); A61K 31/20 (2006.01); A61K 31/353 (2006.01); A61K 31/575 (2006.01); A61K 31/7032 (2006.01); C07D 513/04 (2006.01); C07D 319/18 (2006.01); A61K 31/201 (2006.01); C07D 495/04 (2006.01); G01N 33/92 (2006.01); C07D 471/04 (2006.01); C07D 493/04 (2006.01); C07D 401/14 (2006.01); C07D 401/04 (2006.01); A61K 9/00 (2006.01); A61K 31/506 (2006.01);
U.S. Cl.
CPC ...
A61K 31/5377 (2013.01); A61K 9/0053 (2013.01); A61K 31/155 (2013.01); A61K 31/194 (2013.01); A61K 31/198 (2013.01); A61K 31/20 (2013.01); A61K 31/201 (2013.01); A61K 31/353 (2013.01); A61K 31/4365 (2013.01); A61K 31/506 (2013.01); A61K 31/575 (2013.01); A61K 31/7032 (2013.01); C07D 319/18 (2013.01); C07D 401/04 (2013.01); C07D 401/14 (2013.01); C07D 471/04 (2013.01); C07D 493/04 (2013.01); C07D 495/04 (2013.01); C07D 513/04 (2013.01); G01N 33/92 (2013.01); G01N 2800/52 (2013.01);
Abstract
The invention relates to classes of pharmaceutically-active heterocyclic compounds and pharmaceutically acceptable salts, and hydrates thereof, and compositions comprising the same. The invention also relates to methods for treating or preventing a disease or disorder, which comprises administering a therapeutically or prophylactically effective amount a compound described herein.